Maxim Group analyst Anthony Vendetti has reiterated their bullish stance on HLF stock, giving a Buy rating yesterday.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Anthony Vendetti has given his Buy rating due to a combination of factors, including Herbalife’s stronger-than-expected 4Q25 performance and encouraging forward guidance. He highlights that the company beat expectations on net sales, EBITDA, and EPS, is returning to year-over-year revenue growth across key regions, and is seeing healthier distributor trends supported by targeted engagement and training initiatives.
He also emphasizes the long-term upside from Herbalife’s personalized nutrition strategy, particularly through Pro2col and Link BioSciences, now reinforced by Cristiano Ronaldo’s equity stake and global sponsorship reach. Finally, Vendetti believes the stock’s valuation remains attractive, as HLF trades at a meaningful discount to peers despite measurable progress in its turnaround and the growth opportunities from recurring, higher-quality personalized nutrition revenue.
In another report released yesterday, TipRanks – PerPlexity also upgraded the stock to a Buy with a $18.50 price target.
HLF’s price has also changed dramatically for the past six months – from $9.590 to $19.570, which is a 104.07% increase.